about
Texosome-based drug delivery system for cancer therapy: from past to presentCurrent Trends in Development of Liposomes for Targeting Bacterial BiofilmsNanoparticle-based targeted therapeutics in head-and-neck cancerDelivery of gene silencing agents for breast cancer therapyProgress toward therapy with antisense-mediated splicing modulationNucleic acid delivery with microbubbles and ultrasound.The Theranostic Path to Personalized NanomedicineUltrasound-enhanced microfluidic synthesis of liposomes.Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicImprovement of different vaccine delivery systems for cancer therapy.Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Polymer micro- and nanocapsules as biological carriers with multifunctional properties.Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetesAluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccineTransdermal absorption enhancement of rice bran bioactive compounds entrapped in niosomes.Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration.Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinomaNanotechnology-based approaches in anticancer researchNanovector delivery of siRNA for cancer therapyCancer, chitosan nanoparticles and catalytic nucleic acids.Review: doxorubicin delivery systems based on chitosan for cancer therapy.Remote loading of preencapsulated drugs into stealth liposomes.Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.Liposomes as delivery systems for nasal vaccination: strategies and outcomes.Stabilization of liposomes during drying.Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.Dual targeting strategies with bispecific antibodies.Exosome mimetics: a novel class of drug delivery systems.Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.Impacts of nanomedicines in ocular pharmacotherapyDelivery of RNAi therapeutics: work in progress.Delivering the promise of small ncRNA therapeutics.Delivery and targeting of nanoparticles into hair follicles.Nanomedicine for gene therapy.
P2860
Q26778833-62032E67-FAE2-4983-96F2-FDF331A9F14FQ26865495-7F13D9CB-A1E1-48A8-B829-0F420641D86FQ26999699-857B4853-756D-43D9-850C-CB98FBA05327Q27008706-FA01C744-1314-46DF-9945-397B414684E1Q27489807-325C00A8-55FA-4D31-A61C-F8E2FE277D2CQ30384749-516D2B2B-F029-4103-87C5-6608E8AC8EA3Q30437998-17BCD713-9B18-4F7B-995F-A42F586CF557Q30448520-606CAD03-B806-4133-8DD9-A61456B4986EQ33396676-C9FBB081-0379-4EC2-9295-2C3CB7318EA0Q33715708-46DC014D-B680-49DF-83A0-17452BCE0045Q33911056-6A54C7CF-1DA5-4AC0-B125-DF7C1753AA9BQ34506877-6B5E3C28-A15E-4B39-8C53-F8B621AF1BCDQ35086721-541D87C2-EA64-49C3-AF57-155E761E5771Q35116954-69D61307-36BE-49A8-B821-0BAC846FBCF6Q35558002-6EC12F1A-CA16-4825-A96B-A9985D1E8F57Q35651667-0896B8F1-E1D2-405E-ACFF-EDF4F6E03171Q35672984-9BF7F811-2904-48B0-95FC-D2CD8DCD3A7CQ35821851-C854ED00-3D80-4A02-941D-F1FBB401DA15Q35837680-139F66A4-A7C4-44FA-AD83-5DA925B783AAQ35972521-3162D7AA-C35C-454F-BA62-1A9BDD1CC8B7Q36014101-59729779-025B-4FE8-B651-6C3CC895C86EQ36168983-5526A420-552C-484D-A268-A78E0874C82CQ37347097-E1B78130-B3E5-4570-95A0-D7A807700E69Q37363420-9CD9D822-48D2-4EFE-8A05-F02F8388176EQ37380142-C888D83E-1EE7-4D51-BA0C-0E4A165D6E70Q37587698-B9534EF7-2AC3-4788-BA40-938592388B3BQ37659987-E7A2CECD-3216-4A65-8DB0-0936392B2CB4Q37668050-1DAD6FF9-2CC4-407D-994F-17DFA3340560Q37724374-6D1B8351-1D0B-4B5D-AC19-ED0245BC0BE2Q37748791-F65E791B-76E4-45D7-9A0B-3607DFEEFE94Q37835823-3EFD633B-AB67-460B-AC17-C866D63D047FQ37976494-AD143F21-C393-43A4-8365-053ACD0A8D24Q37997559-B12A95FA-37D4-405F-B0B9-59BF38911E95Q38012446-387603E0-4651-487B-B6A8-4BA3BC5FC7F4Q38090525-77F32DEE-FA8D-4031-A25B-FBD2F39D8B2AQ38107200-58FF1AF7-D8A8-4861-80A3-3710A7901F12Q38160246-C4CD4CB7-78A4-4B9C-843F-2A2EAF63A1E0Q38226666-25643505-E758-441D-8B5D-7466374A46A6Q38265615-F2276470-3CB0-4CE7-ABA6-BBCDFE483F86Q38383478-8278D625-B9AE-4D9E-BC4A-CC6FAD44C761
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liposomal nanomedicines.
@en
Liposomal nanomedicines.
@nl
type
label
Liposomal nanomedicines.
@en
Liposomal nanomedicines.
@nl
prefLabel
Liposomal nanomedicines.
@en
Liposomal nanomedicines.
@nl
P2860
P356
P1476
Liposomal nanomedicines.
@en
P2093
David B Fenske
Pieter R Cullis
P2860
P356
10.1517/17425247.5.1.25
P407
P577
2008-01-01T00:00:00Z